Remarkably, the identified pre-exhausted KLRG1+EOMES+CD28+ cluster was well represented also in periphery, sharing a phenotypical and functional signature with tumor infiltrating T cells, thus likely providing a feasible tool for the identification of responsive patients. This evidence concerns the gene CD28 and neoplasm.